QA: Metavia Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2021_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 10, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 10,683,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 155,000
3 remainder_Assets 130,000
4 LiabilitiesCurrent 3,695,000
5 LiabilitiesNoncurrent 70,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,815,353
9 ResearchAndDevelopmentExpense 21,778,300
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,836
13 remainder_ComprehensiveNetIncome 6,639
  yvar yval
0 Assets 10,968,000
1 Liabilities 3,765,000
2 Expenses 29,593,653
3 Revenues 0
4 StockholdersEquity 7,203,000
5 NetIncome -29,595,489
6 ComprehensiveNetIncome -29,592,170
7 BaseVar 22,167,564
8 EconomicCapitalRatiobeforeLimitedLiability -1.89
9 EconomicCapitalRatio 1.06

Edgar->Model Mapping

Feature Distribution

Change over Time